Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment.

Caroline Robert; Georgina V. Long; Jacob Schachter; Ana Arance; Jean Jacques Grob; Laurent Mortier; Adil Daud; Matteo S. Carlino; Catriona M. McNeil; Michal Lotem; James M. G. Larkin; Paul Lorigan; Bart Neyns; Christian U. Blank; Teresa M. Petrella; Omid Hamid; Honghong Zhou; Blanca Hornet Moreno; Nageatte Ibrahim; Antoni Ribas

doi:10.1200/JCO.2017.35.15_suppl.9504

Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment.

Caroline Robert, Georgina V. Long, Jacob Schachter, Ana Arance, Jean Jacques Grob, Laurent Mortier, Adil Daud, Matteo S. Carlino, Catriona M. McNeil, Michal Lotem, James M. G. Larkin, Paul Lorigan, Bart Neyns, Christian U. Blank, Teresa M. Petrella, Omid Hamid, Honghong Zhou, Blanca Hornet Moreno, Nageatte Ibrahim, Antoni Ribas

Research output: Contribution to journal › Meeting abstract (Journal)

Original language	English
Pages (from-to)	9504-9504
Journal	Journal of Clinical Oncology
Volume	35
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2017.35.15_suppl.9504
Publication status	Published - 20 May 2017
Event	2017 ASCO Annual meeting - Chicago, United States Duration: 2 Jun 2017 → 6 Jun 2017

Access to Document

10.1200/JCO.2017.35.15_suppl.9504

Cite this

Robert, C., Long, G. V., Schachter, J., Arance, A., Grob, J. J., Mortier, L., Daud, A., Carlino, M. S., McNeil, C. M., Lotem, M., Larkin, J. M. G., Lorigan, P., Neyns, B., Blank, C. U., Petrella, T. M., Hamid, O., Zhou, H., Moreno, B. H., Ibrahim, N., & Ribas, A. (2017). Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment. Journal of Clinical Oncology, 35(15), 9504-9504. https://doi.org/10.1200/JCO.2017.35.15_suppl.9504

Robert, Caroline ; Long, Georgina V. ; Schachter, Jacob ; Arance, Ana ; Grob, Jean Jacques ; Mortier, Laurent ; Daud, Adil ; Carlino, Matteo S. ; McNeil, Catriona M. ; Lotem, Michal ; Larkin, James M. G. ; Lorigan, Paul ; Neyns, Bart ; Blank, Christian U. ; Petrella, Teresa M. ; Hamid, Omid ; Zhou, Honghong ; Moreno, Blanca Hornet ; Ibrahim, Nageatte ; Ribas, Antoni. / Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment. In: Journal of Clinical Oncology. 2017 ; Vol. 35, No. 15. pp. 9504-9504.

@article{3ac2763f42024f059970fe3f92ce9d82,

title = "Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment.",

author = "Caroline Robert and Long, {Georgina V.} and Jacob Schachter and Ana Arance and Grob, {Jean Jacques} and Laurent Mortier and Adil Daud and Carlino, {Matteo S.} and McNeil, {Catriona M.} and Michal Lotem and Larkin, {James M. G.} and Paul Lorigan and Bart Neyns and Blank, {Christian U.} and Petrella, {Teresa M.} and Omid Hamid and Honghong Zhou and Moreno, {Blanca Hornet} and Nageatte Ibrahim and Antoni Ribas",

year = "2017",

month = may,

day = "20",

doi = "10.1200/JCO.2017.35.15_suppl.9504",

language = "English",

volume = "35",

pages = "9504--9504",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "2017 ASCO Annual meeting, ASCO ; Conference date: 02-06-2017 Through 06-06-2017",

}

Robert, C, Long, GV, Schachter, J, Arance, A, Grob, JJ, Mortier, L, Daud, A, Carlino, MS, McNeil, CM, Lotem, M, Larkin, JMG, Lorigan, P, Neyns, B, Blank, CU, Petrella, TM, Hamid, O, Zhou, H, Moreno, BH, Ibrahim, N & Ribas, A 2017, 'Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment.', Journal of Clinical Oncology, vol. 35, no. 15, pp. 9504-9504. https://doi.org/10.1200/JCO.2017.35.15_suppl.9504

Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment. / Robert, Caroline; Long, Georgina V.; Schachter, Jacob; Arance, Ana; Grob, Jean Jacques; Mortier, Laurent; Daud, Adil; Carlino, Matteo S.; McNeil, Catriona M.; Lotem, Michal; Larkin, James M. G.; Lorigan, Paul; Neyns, Bart; Blank, Christian U.; Petrella, Teresa M.; Hamid, Omid; Zhou, Honghong; Moreno, Blanca Hornet; Ibrahim, Nageatte; Ribas, Antoni.

In: Journal of Clinical Oncology, Vol. 35, No. 15, 20.05.2017, p. 9504-9504.

Research output: Contribution to journal › Meeting abstract (Journal)

TY - JOUR

T1 - Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment.

AU - Robert, Caroline

AU - Long, Georgina V.

AU - Schachter, Jacob

AU - Arance, Ana

AU - Grob, Jean Jacques

AU - Mortier, Laurent

AU - Daud, Adil

AU - Carlino, Matteo S.

AU - McNeil, Catriona M.

AU - Lotem, Michal

AU - Larkin, James M. G.

AU - Lorigan, Paul

AU - Neyns, Bart

AU - Blank, Christian U.

AU - Petrella, Teresa M.

AU - Hamid, Omid

AU - Zhou, Honghong

AU - Moreno, Blanca Hornet

AU - Ibrahim, Nageatte

AU - Ribas, Antoni

PY - 2017/5/20

Y1 - 2017/5/20

U2 - 10.1200/JCO.2017.35.15_suppl.9504

DO - 10.1200/JCO.2017.35.15_suppl.9504

M3 - Meeting abstract (Journal)

VL - 35

SP - 9504

EP - 9504

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 15

T2 - 2017 ASCO Annual meeting

Y2 - 2 June 2017 through 6 June 2017

ER -